APA aipamena

Khurana, S., Verma, N., Yewdell, J. W., Hilbert, A. K., Castellino, F., Lattanzi, M., . . . Golding, H. (2011). MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines.

Chicago Style aipamena

Khurana, Surender, Nitin Verma, Jonathan W. Yewdell, Anne Katrin Hilbert, Flora Castellino, Maria Lattanzi, Giuseppe Del Giudice, Rino Rappuoli, and Hana Golding. MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines. 2011.

MLA aipamena

Khurana, Surender, et al. MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines. 2011.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.